Dyslipidemia and atypical antipsychotic drugs.

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

2004 • 6,926 citations

High density lipoprotein as a protective factor against coronary heart disease

1977 • 5,019 citations

Coronary Plaque Disruption

1995 • 3,542 citations

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

1989 • 3,169 citations

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1986 • 2,283 citations

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

2003 • 1,462 citations

A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction

1996 • 1,065 citations

Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors

2000 • 394 citations

Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients

2003 • 355 citations

High-density lipoproteins: Epidemiologic profile and risks of coronary artery disease

1983 • 247 citations

Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia

2003 • 230 citations

Atherogenic dyslipidemia and the metabolic syndrome.

2005 • 196 citations

Clozapine Use in Patients With Schizophrenia and the Risk of Diabetes, Hyperlipidemia, and Hypertension

2001 • 195 citations

Drug-Induced Lipid Changes

2001 • 119 citations